|
 |
Company Introduction |
Hunan province Yi kang bio-tech co., Ltd. established in Huaihua City, Hunan province, in October 2002 should merchants moved to Changsha Hunan provincial government national bio-pharmaceutical industrial base was a biotechnology research, development, Production and sales of complex high-tech modern enterprise, Hunan province torch plan, high-tech enterprises, Ministry of science and technology innovation fund to support projects. registered capital is 20 million Yuan, covers an area of 50 acres, the construction area of 18,000 square meters, with total assets of nearly $ 200 million company from Changsha city 30 km, 18 km from the huanghua airport, 319 national highway from the Park through the traffic is very convenient. the company currently employs 186 people, Associate Professor, which is 15, 4 Dr, and 76 above intermediate professional title research management team, is a fine idea ahead, management, dynamic and pioneering spirit of high quality staff. company has strong of development strength, and wide enrollment World Elite, created has themselves of research institutions--Hunan Yi kang bioengineering Institute, and Shanghai Yi kang bioengineering Institute, and Tibet Cordyceps Institute, has research personnel more than 10 over and the a large number of middle research backbone, and by and China Medical Sciences, and Hunan at National Taiwan Normal University, and jishou University of cooperation, training has large of reserve research personnel. company has started throughout the country of the first, the largest and the most technologically advanced of the fruiting of Cordyceps Militaris culture base, produce fruiting of Cordyceps 50 tons.2001 years and 2004 respectively by Hunan province Technology Office Organization by Chinese Academy of Sciences, related expert identification of "North Cordyceps sinensis child entity scale production (Xiang branch mirror [2001] 55th,)" and "high yield quality North Cordyceps child entity production technology research (Xiang branch mirror [2004] No. 006,)" two items technology results identification, think: the project of research is application Foundation and the industrialization technology research, for medicinal fungi learn research method provides has has value of information, " Free pair of Cordyceps multigenerational breeding not variation technique "with breakthrough innovations, is in the domestic leading level; high yield and good quality of Cordyceps Militaris entity production technology research is international leading level; get Changsha technology progress first prize; rich Cordyceps pigment North Cordyceps training and the processing under is as Hunan province torch plans project; while, I company in Cordyceps pigment of research in the has master has stability high yield child entity production and the high purity Cordyceps pigment extraction technology, first found 3 '-deoxidation glands Glycoside (Cordyceps pigment) drop lipid role, has has development in China has independent intellectual property of drop lipid drug conditions, Cordycepin is blood lipid lowering drug patent (patent number: ZL200310101650.7). development out has live Cordyceps, and Cordyceps dry products series, and Cordyceps wine series, and Cordyceps capsule series, and Cordyceps compound capsule series, variety rich Cordyceps pigment (natural anticancer antibiotics) series; to seeks long-term development, improve enterprise of core competitiveness, company currently are started development has high added value of high purity Cordyceps pigment products, cordyceps pigment is Cordyceps of main effective ingredients, is so far found of only of nuclear Glycoside class natural anticancer antibiotics, apart from on bladder cancer, and kidney cancer, and colon cancer, and lung cancer, and breast cancer, and Embryonic cell tumor of prostate cancer cells and fiber has significant anticancer activity, nasopharyngeal cancer, skin cancer, and uterine cancer an inhibitory role in cancer cells, it also can promote cell differentiation, rebuild the cytoskeleton, especially on I-AIDS and reverse transcriptase inhibition activity. in recent years, cordycepin as an important source of anticancer drug intermediates and anti-AIDS drugs made a lot of in-depth studies and clinical trials, in the United States basically completed the phase III clinical study, anti-cancer, anti-AIDS breakthrough had been achieved. but because of cordycepin of Cordyceps raw materials – fruiting body is very scarce, natural content of cordycepin on average only 0 . 2%, it is difficult to develop on a large scale and application of cordycepin. our company independent research and development of technology of high yield and high quality enrichment of cordycepin of Cordyceps Militaris Cordyceps Militaris by 32% output, content of cordycepin in Cordyceps Militaris fruit body of up to 4 . 28%, more than 2000 times higher than natural Cordyceps, of cordycepin solves bottleneck for development and mass production (raw materials), laid the foundations for the research and development of high-purity of cordycepin. Cordyceps Militaris have unlimited development potential and broad market prospects, company development has been the strong support of Governments and relevant departments at all levels. Politburo member, and National Committee President Jia Qinglin cordial interview company Chairman Zhang Xiaojun Mr, Yang zhengwu, and Yu Youjun, and He Tongxin, and Mei Kebao, province led has came to company inspections and guide work, CCTV, and people's daily, over media on company of North Cordyceps project for has topics publicity reported, province development and Reform Commission led, and Liuyang municipal, and Government, and Park led more is give has height of attention and care; Chairman Zhang Xiaojun Mr is CPPCC reported under Hired as Senior Advisor and by the Liuyang city top ten economic news. in 2003, during the anti-SARS products of Cordyceps sponsor $ 6 million, in the "hope project", "sleepy student", "save the mothers" stars were active in charitable activities, such as multiple sponsors, took on a corporate social responsibility should be made. 。
|